Author guidelines

  1. Aims and Scope

1.1 Scientific Journal “Biological Markers in Fundamental and Clinical Medicine” ISSN 2570-5911; eISSN 2570-5903, DOI-prefix 10.29256 (official specialized scientific journal of The Czech Republic, registration number MKCRE 22955) provides a platform for the dissemination of research and reviews in the field of biological markers. The aim of Biological Markers in Fundamental and Clinical Medicine is to advance, impact and communicate all aspects of the use of biological markers for diagnostics, treatment and prophylaxis.

1.2. Biological Markers in Fundamental and Clinical Medicine publishes original articles, reviews, editorials, news and commentaries, letters to the editors and correspondences, abstracts of the conferences in all fields of clinical and basic medicine, pharmacology, molecular biology and genetics related to the use of biological markers.

1.3. Papers are accepted if criteria regarding quality and originality of the research and its significance to journal readership are fulfilled. Authors of the paper are responsible for the originality and reliability of the data. Editors office can make correction of the text of the paper if it would be needed.

1.4. Papers will only be sent to the publishing after review and if the paper meets the appropriate quality and relevance requirements. Date when the article was finally prepared (after review and correction) will be indicated in the printed version. Authors of articles which are accepted and published in Biological Markers in Fundamental and Clinical Medicine grant right to use (share and adapt), reproduce and disseminate their article to the editors of the Biological Markers in Fundamental and Clinical Medicine for any purpose, even commercially. Open access publishing enables free access to all content ensuring a wide dissemination of articles.

1.5. Papers must be submitted in English. Article must be sent by e-mail (please indicate “Article” in the title of the e-mail) to escbm@escbm.org. Text (doc file - in Microsoft Word for Windows, 6.0) should be enclosed to the letter. Also additional files with scan-copy (jpeg format) of the first page of the article with sighs of all authors of the article and additional file (doc file) with information about the authors with contact details (occupation, position, e-mail, telephone number, address of the author, who is responsible for correspondence) should be attached to the e-mail.

1.6. Final decision of the editorials office regarding each paper is based on the COPE’s criteria for publication ethics (COPE: www.publicationethics.org/resources/flowcharts).

1.7. Once the article is reviewed, the author will receive an email notification. Author is responsible for final correction of the paper and must sent corrected article back to the editorial office (escbm@escbm.org) during not more than 21 days. Otherwise the paper will be scrubbed. Please note that the author is responsible for all statements made in their work, including changes made during the editorial process – authors should check proofs carefully.

1.8. Application of the paper and reviewing process is free of charge. Publication Charge is 50€ for each article accepted for publication, plus taxes where applicable. The author will be notified if the article is finally approved for publication, along with instructions on how to pay for the charges.

  1. Instructions for authors. Manuscript preparation

2.1. Manuscripts must be grammatically and linguistically correct, and authors less familiar with English usage are advised to seek the help of English-speaking colleagues. Authors may also choose to have their manuscript professionally edited before submission or during the review process

2.1. The manuscript should be prepared using Word system, basic font TimesNewRoman 14pt size. The papers should be with margins 2.5 cm on left and right, top and bottom on A4-format white paper with numeration in the right bottom margin. Tables, images should be places in the corresponding part of the text.

2.2 Title of the manuscript should be in capital letters. Then names of the authors should be given in the next line. Than should be indicated institutions where this study was executed. In the next line authors should write up to 10 key words.

Short abstract of the article (not less than 100, not more than 250 words) should have the same structure/sections, as the manuscript, reflect all important results and conclusions.

2.3 Research Articles should be divided into the following sections: 1 Introduction 2 Materials and methods 3 Results and Discussion 5 Acknowledgements (founding sources and conflict of interests) 6 References.

2.4 The section “Introduction” should contain a description of the problem under investigation and a brief survey of the existing literature on the subject with references on the other existing researches in this field of science. The study rationale and aim of the study should also be clearly described.

2.5 The section “Materials and methods” should describe all materials and methods used in the study. Better to refer to previously published descriptions of methods and provide only a brief summary of the method. Any modifications to published methods should be described in detail. Sources (name and location) of reagents and equipment and information regarding experimental animals should be provided.

2.6 The section “Results and discussion” should clearly describe the main experimental finding of the study with statistical proof. Authors are encouraged to describe the findings in light of current knowledge and compare with data of other authors from the literature (with indication of the reference). It should enrich, but not repeat, the “Introduction” section.

2.7 References are to be collected in numerical order (by the order of the citing in the text) at the end of the manuscript under the heading “References” on the separate page. Unpublished should NOT be included in the reference list.

An example:

1. Machandran A.,Snehalatha C., Mary S. et al.The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) //Diabetologia. 2006; 49: 289-297.